lysine has been researched along with enalaprilat anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, JL; Nichols, WW; Saldeen, K; Saldeen, TG; Wallin, R | 1 |
| Brovkovych, V; Erdös, EG; Ignjatovic, T; Skidgel, RA; Tan, F | 1 |
2 other study(ies) available for lysine and enalaprilat anhydrous
| Article | Year |
|---|---|
Replacement of L-Lys by D-Lys(NH2) in peptide Ala-Arg-Pro-Ala-Lys (peptide 6A) increases its coronary blood flow-promoting properties.
Topics: Amino Acid Sequence; Animals; Blood Pressure; Coronary Circulation; Dogs; Enalaprilat; Fibrin Fibrinogen Degradation Products; Histamine Release; Lysine; Mast Cells; Molecular Sequence Data; Peptidyl-Dipeptidase A; Rats; Vascular Resistance | 1994 |
Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Binding Sites; Binding, Competitive; Calcium; Cell Line; Chelating Agents; CHO Cells; COS Cells; Cricetinae; DNA, Complementary; Dose-Response Relationship, Drug; Edetic Acid; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Fibroblasts; Histidine; Humans; Ligands; Lysine; Mutagenesis, Site-Directed; Nitric Oxide; Protein Binding; Protein Structure, Tertiary; Receptor, Bradykinin B1; Receptors, Bradykinin; Transfection; Zinc | 2002 |